Business
BioSpectrum Asia
Australia approves first and only treatment for chronic hypoparathyroidism
Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has received the registration of YORVIPATH (palopegteriparatide) by the Therapeutic Goods Administration (TGA), for the treatment of chronic hypoparathyroidism in adults.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Bruker introduces X4 POSEIDON advanced X-ray microscope for scientific applications
American manufacturer of scientific instruments Bruker Corporation has announced the launch of the new X4 POSEIDON, a high-performance 3D X-ray microscope (XRM) using micro Computed Tomography (microCT).
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Sun Pharma buys Checkpoint Therapeutics for $255 M
India-based Sun Pharmaceutical Industries Limited and US-based Checkpoint Therapeutics, Inc. have entered into an agreement by which Sun Pharma will acquire Checkpoint, an immunotherapy and targeted oncology company.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
"ADCS have already become a mainstay treatment option across a variety of both hematologic and solid cancers"
The resurgence of antibody-drug conjugates (ADCs) in cancer therapy signifies a shift towards targeted, highly effective treatments, leveraging the power of monoclonal antibodies to deliver potent cytotoxic payloads directly to cancer cells, minimising harm to healthy tissues.
5 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Lunit expands partnership with Saudi Arabia's largest medical group to deploy AI chest X-ray solution
South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, has announced a second agreement with Cloud Solutions, a subsidiary of Dr. Sulaiman AI Habib Medical Group (HMG), Saudi Arabia's largest medical organisation.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Parse Biosciences plans to release single cell chromatin accessibility products
The US-based Parse Biosciences, the leader in accessible and scalable single cell sequencing, has affirmed plans to proceed with development and future release of their Evercode single cell chromatin products.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
PerkinElmer acquires Project Farma to expand services for life sciences industry
PerkinElmer, a global leader in analytical solutions and specialised services for biopharma, applied and food markets, has announced the acquisition of Project Farma, a subsidiary of Precision for Medicine.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Astellas and Yaskawa to establish joint venture in Japan focused on cell therapy manufacturing
Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement to establish a joint venture for the development of a cell therapy product manufacturing platform utilising the dual-arm robot 'Maholo'.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
India builds AI-powered model to improve blood sugar predictions for diabetes management
A research team at National Institute of Technology (NIT) Rourkela, India has developed a new artificial intelligence (AI)driven approach to improve blood sugar predictions for people with diabetes.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Singapore announces expansion of healthcare capacity
The Ministry of Health (MOH) in Singapore plans to continue to transform and strengthen its healthcare workforce, in tandem with capacity expansion.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Thailand designs exoskeleton wheelchair to aid mobility
Thailand's Chulalongkorn University has introduced the Exoskeleton Wheelchair, an innovative robotic suit designed to help people with disabilities stand, walk, and move more independently.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
"Biggest challenge in running a chronic Hepatitis B trial is often patient recruitment"
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released its latest disease report: Hepatitis B - Global Clinical Trial Landscape (2025) in March 2025.
5 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Callio Therapeutics launches with $187 M Series A round to advance multi-payload ADC platform
Callio Therapeutics, a Singapore and US-based biotechnology startup focused on realising the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, has announced its launch with the closing of a $187 million Series A financing round.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
PolyU and Peking University explore collaboration in medical technology in China
The Hong Kong Polytechnic University (PolyU) and Peking University Health Science Center (Peking University) have signed a Memorandum of Understanding (MoU) to explore collaboration in the field of medical technology, including joint research and faculty and student exchanges.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Insilico Medicine secures $110 M Series E financing to advance Al-driven drug discovery innovation
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery startup headquartered in Hong Kong, has successfully secured a $110 million Series E financing led by a private equity fund of Value Partners Group, one of Asia's largest independent asset management firms, with strong participation from industry- and technology-focused new investors, as well as continued support from global existing backers.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Docquity introduces AI-powered medical resource platform in Indonesia
Docquity, a leading healthtech company in Southeast Asia, and Rumah Sakit Umum Daerah (RSUD) Umar Wirahadikusumah Sumedang, a regional hospital in West Java, Indonesia, have announced a partnership to integrate Dx, Docquity's artificial intelligence (AI)-powered medical resource platform, into the hospital's medical reference system.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
"Encephalitis is associated with significant costs to individuals and society, due to its high morbidity and mortality"
World Health Organization (WHO) and United Kingdom-headquartered Encephalitis International launched a critical Technical Brief on Encephalitis in London on February 20 as World Encephalitis Day celebrated on February 22 every year.
2 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Advancing Green Pharmaceuticals: Sustainable Biomanufacturing Practices Across APAC
The pharmaceutical industry is at a critical juncture, urgently needing to transform towards sustainability to reduce its environmental footprint.
7 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
"AI will shift the focus of healthcare professionals toward higher-value tasks like clinical decision-making"
Australian AI-powered medical imaging company, Harrison.ai, has secured $112 million in Series C funding to accelerate product development, expand clinical partnerships, and scale its global presence.
4 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
CDMOS Clean Up Act: Environmental Responsibility
Sustainability is no longer a buzzword in the background, but has become critical as the pharmaceutical industry faces evolving regulations and growing environmental concerns.
10+ min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Boehringer Ingelheim enhances biopharma contract manufacturing services in China
Boehringer Ingelheim's biopharmaceutical facility in Shanghai, China, meets the conditions to participate in a regulatory reform promoting segmented manufacturing of biological products by the local authorities.
1 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Healing an Ailing MedTech Talent Ecosystem
The Asia-Pacific (APAC) region represents a critical landscape for the future of medical technology. However, a thriving medical technology sector needs people skilled in engineering, product development and manufacturing. With advances in artificial intelligence (AI) and robotic surgeries driving a big transformation and creating new opportunities, it is also deepening the skills gap many workers face. Let's take a closer look at these gaps and the solutions that are emerging to address those gaps.
7 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
"Affordability remains a big concern for Indian ophthalmology market"
Currently, India faces a growing eye-health concern with approximately 4.95 million blind persons and 70 million vision-impaired individuals, including 240,000 blind children.
4 min |
BioSpectrum Asia April 2025
BioSpectrum Asia
Inventia announces groundbreaking advancement in 3D cell culture technology
Inventia Life Science, an innovator in 3D cell culture technologies, has announced the launch of RASTRUM Allegro, a groundbreaking advancement in 3D cell culture technology designed to accelerate drug discovery and disease research with unprecedented scalability, reproducibility, and efficiency.
1 min |
March 2025
BioSpectrum Asia
Aphra names Justin Untersteiner as CEO
The Australian Health Practitioner Regulation Agency (Ahpra) has appointed Justin Untersteiner as Chief Executive Officer (CEO).
1 min |
March 2025
BioSpectrum Asia
WHO partners with Siriraj Hospital in Thailand to address growing burden of injuries and falls
The World Health Organization (WHO) has signed a Memorandum of Understanding (MoU) with Siriraj Hospital, Mahidol University, Thailand, to strengthen collaboration on trauma, injury, and fall prevention across the WHO South-East Asia Region to address the growing health, social, and economic challenges posed by these issues.
1 min |
March 2025
BioSpectrum Asia
Jubilant Biosys expands footprint in Europe for Biologics and Antibody Drug Conjugate services
Jubilant Biosys Innovative Research Services Pte Limited, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, has executed the transaction definitive agreements with Pierre Fabre (PF) SA, and its affiliate entities, for JBIRSPL to acquire 80 per cent equity capital in JASMIN (new company incorporated by PF in France, as a Société par Actions Simplifiée (SAS)), with remaining 20 per cent retained by PF.
1 min |
March 2025
BioSpectrum Asia
PanopticAI gets US FDA clearance for contactless vital signs monitoring software
PanopticAI, a startup in remote patient monitoring space, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its contactless vital signs monitoring software.
1 min |
March 2025
BioSpectrum Asia
Immuneel unveils India's first global CAR T-cell therapy for Non-Hodgkin's Lymphoma
In a significant step forward for India’s cancer treatment, Immuneel Therapeutics has unveiled Qartemi, country’s first global CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL), a group of blood cancers.
1 min |
March 2025
BioSpectrum Asia
Axel Klarmeyer joins as CEO at Chamlion International
China-based Chamlion, a pioneer in integrated dental 3D printing solutions, has announced the appointment of Axel Klarmeyer as the Chief Executive Officer (CEO) of Chamlion International, overseeing the company's international business operations.
1 min |